APA (7th ed.) Citation

MS, D., A, D., H, T., JB, O., M, H., A, O., . . . AVS, H. (2024). Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: A multicentre, double-blind, randomised, phase 3 trial. Lancet (London, England), 403(10426), 533. https://doi.org/10.1016/S0140-6736(23)02511-4

Chicago Style (17th ed.) Citation

MS, Datoo, et al. "Safety and Efficacy of Malaria Vaccine Candidate R21/Matrix-M in African Children: A Multicentre, Double-blind, Randomised, Phase 3 Trial." Lancet (London, England) 403, no. 10426 (2024): 533. https://doi.org/10.1016/S0140-6736(23)02511-4.

MLA (9th ed.) Citation

MS, Datoo, et al. "Safety and Efficacy of Malaria Vaccine Candidate R21/Matrix-M in African Children: A Multicentre, Double-blind, Randomised, Phase 3 Trial." Lancet (London, England), vol. 403, no. 10426, 2024, p. 533, https://doi.org/10.1016/S0140-6736(23)02511-4.